Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Cross-sectional associations of tau protein biomarkers with semantic and episodic memory in older adults without dementia: A systematic review and meta-analysis

Pelgrim TAD, Beran M, Twait EL, Geerlings MI, Vonk JMJ.

Ageing Res Rev. 2021 Nov;71:101449. doi: 10.1016/j.arr.2021.101449. Epub 2021 Aug 13.

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study

Tofiq A, Zetterberg H, Blennow K, Basun H, Cederholm T, Eriksdotter M, Faxén-Irving G, Hjorth E, Jernerén F, Schultzberg M, Wahlund LO, Palmblad J, Freund-Levi Y.

J Alzheimers Dis. 2021;83(3):1291-1301. doi: 10.3233/JAD-210007.

Lactoferrin and Its Detection Methods: A Review

Zhang Y, Lu C, Zhang J.

Nutrients. 2021 Jul 22;13(8):2492. doi: 10.3390/nu13082492.

Challenges in LC-MS-based metabolomics for Alzheimer's disease early detection: targeted approaches versus untargeted approaches

Reveglia P, Paolillo C, Ferretti G, De Carlo A, Angiolillo A, Nasso R, Caputo M, Matrone C, Di Costanzo A, Corso G.

Metabolomics. 2021 Aug 28;17(9):78. doi: 10.1007/s11306-021-01828-w.

Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances

Chong JR, Ashton NJ, Karikari TK, Tanaka T, Schöll M, Zetterberg H, Blennow K, Chen CP, Lai MKP.

J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1231-1241. doi: 10.1136/jnnp-2021-327370. Epub 2021 Sep 11.

Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review

Cianflone A, Coppola L, Mirabelli P, Salvatore M.

J Alzheimers Dis. 2021;84(1):393-407. doi: 10.3233/JAD-210496.

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2022 Apr;18(4):824-857. doi: 10.1002/alz.12422. Epub 2021 Sep 28.

PET Imaging of Neuroinflammation in Alzheimer's Disease

Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, Ni R.

Front Immunol. 2021 Sep 16;12:739130. doi: 10.3389/fimmu.2021.739130. eCollection 2021.

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6

Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, Stephan BCM, Altomare D, Frisoni GB, Ribaldi F, Molinuevo JL, Scheltens P, Llewellyn DJ; European Task Force for Brain Health Services.

Alzheimers Res Ther. 2021 Oct 11;13(1):169. doi: 10.1186/s13195-021-00895-4.

Electroencephalography as a Non-Invasive Biomarker of Alzheimer's Disease: A Forgotten Candidate to Substitute CSF Molecules?

Monllor P, Cervera-Ferri A, Lloret MA, Esteve D, Lopez B, Leon JL, Lloret A.

Int J Mol Sci. 2021 Oct 8;22(19):10889. doi: 10.3390/ijms221910889.

Current research status of blood biomarkers in Alzheimer's disease: Diagnosis and prognosis

Feng L, Li J, Zhang R.

Ageing Res Rev. 2021 Dec;72:101492. doi: 10.1016/j.arr.2021.101492. Epub 2021 Oct 19.

A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach

Tan MS, Cheah PL, Chin AV, Looi LM, Chang SW.

Comput Biol Med. 2021 Dec;139:104947. doi: 10.1016/j.compbiomed.2021.104947. Epub 2021 Oct 14.

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M.

Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.

The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer's disease continuum: A systematic review and meta-analysis with narrative synthesis

Yoong SQ, Lu J, Xing H, Gyanwali B, Tan YQ, Wu XV.

Ageing Res Rev. 2021 Dec;72:101491. doi: 10.1016/j.arr.2021.101491. Epub 2021 Oct 21.

Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease

Wattmo C, Blennow K, Hansson O.

Curr Alzheimer Res. 2021;18(7):573-584. doi: 10.2174/1567205018666211022164952.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias